CTLA4 and neoplasm: Tumor growth of individual treatment groups indicated that there was no significant differential tumor growth among IgG, anti‐CD8, and APG‐157 + anti‐CTLA‐4 + anti‐CD8 antibodies treated groups (Figure 5C–F).